Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Effects of nutritional interventions on biomarkers of cellular senescence in humans: a systematic review.

Ageing research reviews·2026

Same author

Response to: Limitations of the p16-3MR mouse model for detecting and eliminating senescent cells.

EMBO reports·2026

Same author

Public health in the age of longevity interventions: from prevention to system-wide resilience.

Aging·2026

Same author

The Role of CaV3.2 T-type calcium channels in normal hearing and acquired hearing loss.

Cell calcium·2026

Same author

Toward actionable interventions in human aging (12th ARDD meeting, 2025).

Aging·2026

Same author

Dual role of MIF in aging and cellular senescence.

Cytokine & growth factor reviews·2026

Same journal

Itaconate in cancer immunity: Evidence, ambiguities, and translational barriers.

Trends in cancer·2026

Same journal

Patient-derived organoids in hematologic malignancies: Fidelity and translation beyond animals.

Trends in cancer·2026

Same journal

Precision neuro-oncology for children: Time to gear up!

Trends in cancer·2026

Same journal

Multi-omics analysis of extracellular vesicle cargo in cancer.

Trends in cancer·2026

Same journal

An immunological panacea for cancer-related cachexia.

Trends in cancer·2026

Same journal

Beyond one gene, one target: Next-generation precision oncology.

Trends in cancer·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Oct 19, 2025

A Sensitive Method to Quantify Senescent Cancer Cells

A Sensitive Method to Quantify Senescent Cancer Cells

Published on: August 2, 2013

A novel transcriptomic-based classifier for senescent cancer cells.

Feba Mariam Varughese¹, Marco Demaria²

¹European Research Institute for the Biology of Ageing (ERIBA), University Medical Center Groningen (UMCG), University of Groningen (RUG), Antonius Deusinglaan 1, 9713AV Groningen, The Netherlands; Division of Oncology, Department of Translational Medicine, University of Eastern Piedmont, Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy.

Trends in Cancer

|September 22, 2021

Summary

This summary is machine-generated.

Identifying senescent cancer cells is crucial for developing new cancer therapies. A machine-learning classifier based on gene activity was created to accurately detect these cells, aiding senolytic drug development.

More Related Videos

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells

Published on: July 12, 2022

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Published on: June 28, 2019

Related Experiment Videos

Last Updated: Oct 19, 2025

A Sensitive Method to Quantify Senescent Cancer Cells

A Sensitive Method to Quantify Senescent Cancer Cells

Published on: August 2, 2013

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells

Published on: July 12, 2022

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Published on: June 28, 2019

Area of Science:

Oncology
Computational Biology
Molecular Biology

Background:

Senescent cancer cells resist conventional treatments.
Targeting senescent cells with senolytic compounds offers a novel therapeutic strategy.
Accurate identification of senescent cancer cells is a major challenge in oncology.

Purpose of the Study:

To develop a reliable method for identifying senescent cancer cells.
To leverage machine learning for cancer cell classification.
To facilitate the development of senolytic therapies.

Main Methods:

Utilized a machine-learning approach.
Generated a classifier based on transcriptional signatures.
Applied computational methods to gene expression data.

Main Results:

Successfully developed a machine-learning classifier for senescent cancer cells.
The classifier is based on distinct transcriptional signatures.
Demonstrated the potential for accurate senescent cell identification.

Conclusions:

Machine learning offers a powerful tool for identifying senescent cancer cells.
This approach can overcome current limitations in senescent cell detection.
The developed classifier may accelerate the clinical translation of senolytic therapies.